These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 20609203)

  • 1. Investigation of panagglutinating sera.
    Branch DR
    Transfusion; 2010 Mar; 50(3):739-40; author reply 740. PubMed ID: 20609203
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of antisera for bloodstain grouping. II. Ss, Kell, Duffy, Kidd, and Gm/Km.
    Gaensslen RE; Lee HC; Pagliaro EM; Bremser JK; Carroll-Reho J
    J Forensic Sci; 1985 Jul; 30(3):655-76. PubMed ID: 4031801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Day phenotype: a "new" variant in the Kell blood group system.
    Brown A; Berger R; Lasko D; Brokenshire D; Humphreys J; Stout T; Moore BP; Johnson CL; Mueller KA; Marsh WL
    Rev Fr Transfus Immunohematol; 1982 Dec; 25(6):619-27. PubMed ID: 7170568
    [No Abstract]   [Full Text] [Related]  

  • 4. Failure to detect potent anti-H in Parabombay patients with the gel system.
    Cheng G; Choi F; Wong L
    Clin Lab Haematol; 1996 Mar; 18(1):63-4. PubMed ID: 9118612
    [No Abstract]   [Full Text] [Related]  

  • 5. [Erythrocyte blood group in cord blood].
    Gallet M; Brulé-Pépin R; Omanga-Léké ML; Lorriaux C
    J Gynecol Obstet Biol Reprod (Paris); 2002 Sep; 31(5):512. PubMed ID: 12379837
    [No Abstract]   [Full Text] [Related]  

  • 6. Incidence and persistence of anti-Kell after transfusion of Kell-positive blood.
    Schabel A; König AL; Schiebel MR; Sugg U
    Beitr Infusionsther Transfusionsmed; 1994; 32():175-8. PubMed ID: 9422111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Problems in laboratory investigations and management of transfusion in patients with antibodies to high frequency antigens (a report on two cases with anti-Kpb).
    Kumar ND; Martlew VJ
    Indian J Pathol Microbiol; 1994 Oct; 37(4):431-4. PubMed ID: 7868178
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti Kell allo-antibody in a thalassaemic.
    Thakral B; Saluja K; Sharma RR; Marwaha N; Marwaha RK
    Indian J Pathol Microbiol; 2006 Jan; 49(1):37-9. PubMed ID: 16625974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cross matching].
    Wider G
    Infusionsther Klin Ernahr; 1980 Aug; 7(4):206-8. PubMed ID: 6774949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Section 4: Antibodies to other blood group antigens. Coordinator's report.
    Daniels G
    Transfus Clin Biol; 2002 Jan; 9(1):75-80. PubMed ID: 11889902
    [No Abstract]   [Full Text] [Related]  

  • 11. [Isoimmunization to Kell factor, during pregnancy].
    Krug A; Bianchi R; Cornejo A; Farias S; Fuentes L
    Rev Chil Obstet Ginecol; 1988; 53(4):198-200. PubMed ID: 3155245
    [No Abstract]   [Full Text] [Related]  

  • 12. Transfusion medicine illustrated: blocked D phenomenon.
    Moiz B; Salman M; Kamran N; Shamsuddin N
    Transfusion; 2008 Aug; 48(8):1545-6. PubMed ID: 18713103
    [No Abstract]   [Full Text] [Related]  

  • 13. K22, a 'new' para-Kell antigen of high frequency.
    Bar Shany S; Ben Porath D; Levene C; Sela R; Daniels GL
    Vox Sang; 1982 Feb; 42(2):87-90. PubMed ID: 7064432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel KEL*02N allele in Saudi Arabia encoding a Kell null (K
    Albasri J; Alsuhaibani O; Almarry N; Ochoa-Garay G; Bensing KM; Biese D; Knier M; Denomme GA
    Transfusion; 2021 Jul; 61(7):E49-E50. PubMed ID: 34137046
    [No Abstract]   [Full Text] [Related]  

  • 15. A new paradigm for pretransfusion testing with the same perennial limitations.
    Westhoff CM; Anstee DJ
    Transfusion; 2010 Mar; 50(3):520-1. PubMed ID: 20609198
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti Kp a antibody: a rare alloantibody in a multitransfused thalassemic of Indian origin.
    Pahuja S; Pujani M; Gupta SK; Chandra J; Jain M; Vasudeva S
    Indian J Pathol Microbiol; 2010; 53(3):575-6. PubMed ID: 20699537
    [No Abstract]   [Full Text] [Related]  

  • 17. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
    Vućinović M; Jadrić H; Karelović D; Roje D; Haspl-Hundrić Z; Hrgović Z; Vućinović Z
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of severe foetal anaemia due to anti-Kell that could not be detected by the weekly assessment of middle cerebral artery peak systolic velocity.
    Deleers M; Guizani M; Jani J; Hulot M; El Kenz H
    Transfus Apher Sci; 2018 Feb; 57(1):111-113. PubMed ID: 29449170
    [No Abstract]   [Full Text] [Related]  

  • 19. Polyethylene glycol in the production of blood grouping reagents: some further advantages.
    Green C; McColl K; Gibson J; McGowan A; Yap PL
    Med Lab Sci; 1989 Jan; 46(1):81-2. PubMed ID: 2779389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo survival of K:18 red cells in a recipient with anti-K18.
    Barrasso C; Baldwin ML; Drew H; Ness PM
    Transfusion; 1983; 23(3):258-9. PubMed ID: 6679384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.